Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats.

Shan Ji Piao, So Hun Kim, Young Ju Suh, Seong Bin Hong, Seong Hee Ahn, Da Hae Seo, In Sun Park, Moonsuk Nam
Author Information
  1. Shan Ji Piao: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  2. So Hun Kim: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  3. Young Ju Suh: Department of Biomedical Sciences, Inha University School of Medicine, Incheon, Korea.
  4. Seong Bin Hong: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  5. Seong Hee Ahn: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  6. Da Hae Seo: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  7. In Sun Park: Department of Anatomy, Inha University School of Medicine, Incheon, Korea. sunpark@inha.ac.kr. ORCID
  8. Moonsuk Nam: Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea. namms@inha.ac.kr. ORCID

Abstract

BACKGROUND: Regular aerobic exercise is essential for the prevention and management of type 2 diabetes mellitus and may be particularly beneficial for those treated with thiazolidinediones, since it may prevent associated weight gain. This study aimed to evaluate the effect of combined exercise and rosiglitazone treatment on body composition and glucose metabolism in obese diabetes-prone animals.
METHODS: We analyzed metabolic parameters, body composition, and islet profiles in Otsuka Long Evans Tokushima Fatty rats after 28 weeks of aerobic exercise, rosiglitazone treatment, and combined exercise and rosiglitazone treatment.
RESULTS: Combined exercise with rosiglitazone showed significantly less increase in weight and epididymal fat compared to rosiglitazone treatment. Aerobic exercise alone and combined rosiglitazone and exercise treatment led to similar retention of lean body mass. All experimental groups showed a decrease in fasting glucose. However, the combined exercise and rosiglitazone therapy group showed prominent improvement in glucose tolerance compared to the other groups. Rescue of islet destruction was observed in all experimental groups, but was most prominent in the combined therapy group.
CONCLUSION: Regular aerobic exercise combined with rosiglitazone treatment can compensate for the adverse effect of rosiglitazone treatment and has benefit for islet preservation.

Keywords

References

  1. J Clin Endocrinol Metab. 2001 Sep;86(9):4047-58 [PMID: 11549624]
  2. Diabetes Care. 2007 Sep;30(9):2242-4 [PMID: 17586747]
  3. J Appl Physiol (1985). 2012 Mar;112(5):711-8 [PMID: 22174407]
  4. Diabetes Res Clin Pract. 1995 Jul;29(1):1-10 [PMID: 8593753]
  5. PLoS One. 2008 May 14;3(5):e2182 [PMID: 18478115]
  6. J Histochem Cytochem. 2003 Aug;51(8):1005-15 [PMID: 12871982]
  7. Am J Physiol. 1997 Oct;273(4 Pt 1):E727-33 [PMID: 9357802]
  8. Diabetologia. 2012 Jun;55(6):1577-96 [PMID: 22526604]
  9. Diabetes. 2003 Sep;52(9):2331-7 [PMID: 12941773]
  10. Diabetes. 2004 Feb;53 Suppl 1:S43-50 [PMID: 14749265]
  11. J Pharmacol Exp Ther. 2005 Dec;315(3):1020-7 [PMID: 16123307]
  12. Metabolism. 1996 Apr;45(4):475-80 [PMID: 8609834]
  13. Diabetes. 2002 Apr;51(4):1083-7 [PMID: 11916929]
  14. Diabetes. 2007 Jul;56(7):1856-64 [PMID: 17440174]
  15. Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E941-9 [PMID: 17623749]
  16. Metabolism. 2010 Apr;59(4):599-607 [PMID: 19922961]
  17. Diabet Med. 2003 Apr;20(4):294-300 [PMID: 12675643]
  18. Diabetes. 2002 Dec;51(12 ):3479-85 [PMID: 12453903]
  19. Obes Rev. 2003 May;4(2):101-14 [PMID: 12760445]
  20. Atherosclerosis. 2002 May;162(1):85-92 [PMID: 11947901]
  21. Diabet Med. 2005 Aug;22(8):963-72 [PMID: 16026359]
  22. Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1023-9 [PMID: 19706785]
  23. Diabetes. 2003 Jan;52(1):102-10 [PMID: 12502499]
  24. Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E557-65 [PMID: 12556352]
  25. Diabetes. 2000 Dec;49(12):2154-9 [PMID: 11118020]
  26. Diabetologia. 2015 Jan;58(1):10-8 [PMID: 25367458]
  27. Diabetes. 2010 Jun;59(6):1445-50 [PMID: 20332343]
  28. Diabetes. 2005 Jul;54(7):2235-44 [PMID: 15983227]
  29. Diabetes Care. 2015 Jan;38 Suppl:S4 [PMID: 25537706]
  30. Diabetes. 2001 May;50(5):1021-9 [PMID: 11334404]
  31. Diabetes Care. 2009 Oct;32(10):1807-11 [PMID: 19592624]
  32. Metabolism. 2001 Aug;50(8):963-71 [PMID: 11474486]
  33. Dev Dyn. 2004 May;230(1):1-11 [PMID: 15108304]
  34. Hypertension. 2002 Dec;40(6):880-5 [PMID: 12468573]
  35. Am J Clin Nutr. 1997 Sep;66(3):551-6 [PMID: 9280172]
  36. Nat Rev Endocrinol. 2009 Jun;5(6):319-25 [PMID: 19421242]
  37. Obesity (Silver Spring). 2008 Feb;16(2):241-56 [PMID: 18239630]
  38. N Engl J Med. 2006 Dec 7;355(23):2427-43 [PMID: 17145742]
  39. Diabetes Care. 2010 Dec;33(12):e147-67 [PMID: 21115758]

Word Cloud

Created with Highcharts 10.0.0exerciserosiglitazonetreatmentcombinedaerobicbodycompositionglucoseisletshowedgroupsRegularmayweighteffectOtsukaLongEvansTokushimaFattyCombinedcomparedAerobicexperimentaltherapygroupprominentExerciseRosiglitazoneRatsBACKGROUND:essentialpreventionmanagementtype2diabetesmellitusparticularlybeneficialtreatedthiazolidinedionessincepreventassociatedgainstudyaimedevaluatemetabolismobesediabetes-proneanimalsMETHODS:analyzedmetabolicparametersprofilesrats28weeksRESULTS:significantlylessincreaseepididymalfataloneledsimilarretentionleanmassdecreasefastingHoweverimprovementtoleranceRescuedestructionobservedCONCLUSION:cancompensateadversebenefitpreservationBeneficialEffectsTrainingGlucoseMetabolismBeta-cellBodyDiabetesinbredOLETF

Similar Articles

Cited By